Trail­ing the Big Phar­ma play­ers, a less­er known BC­MA CAR-T can­di­date comes in­to the spot­light

Bris­tol My­ers Squibb and blue­bird cleared the first BC­MA CAR-T ther­a­py for mul­ti­ple myelo­ma pa­tients back in March, and J&J and their part­ners at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.